Skip to content
lifestyle.thenyctimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ONCOVITA
Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission
November 9, 2026
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
June 4, 2026